Clinical Trial Update: Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial evaluating the efficacy of a chemotherapy-targeted therapy combination in breast cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Chemotherapy-Targeted Therapy

Snippet

Sponsor: Centre Jean Perrin | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED